SCHEMBL7259185

SCHEMBL7259185

NC(=O)c1n[c]c(N)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14091342 0.64 PDPK1 (0.36) —
SCHEMBL2346673 0.63 — —
SCHEMBL8670138 0.60 KDM4E (0.32) —
SCHEMBL4455585 0.60 PDPK1 (0.31) —
SCHEMBL2977574 0.59 — —
SCHEMBL2233666 0.59 — —
SCHEMBL12050697 0.57 LMNA (0.37) —
SCHEMBL28195767 0.57 — —
SCHEMBL11778516 0.57 PDPK1 (0.58) —
SCHEMBL1921176 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051881-A1 SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES RIBAPHARM INC. (US) 2003-06-26 — — WO claimed
WO-2003051881-A1 SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES RIBAPHARM INC. (US) 2003-06-26 — — WO disclosed
Send feedback